Plasma/albumin-free recombinant coagulation factor VIII
Indications/Uses
Control & prevention of bleeding episodes & for routine & surgical prophylaxis in patients w/ hemophilia A (congenital factor VIII deficiency/classic hemophilia). Xyntha does not contain von Willebrand factor & therefore is not indicated in patients w/ von Willebrand's disease.
Individualised dosage. Early hemarthrosis, minor muscle/oral bleeds 20-40 IU/dL 12-24 hrly for at least 1 day. Bleeding into muscles/oral cavity, mild head trauma 30-60 IU/dL 12-24 hrly for 3-4 days. GI, intracranial, intra-abdominal or intrathoracic bleeding, fractures 60-100 IU/dL 8-24 hrly. Minor surgery 30-60 IU/dL 12-24 hrly for 3-4 days. Tooth extraction 30-60 IU/dL single infusion + oral antifibrinolytic therapy w/in 1 hr. Major surgery 60-100 IU/dL 8-24 hrly. Routine prophylaxis Adult & adolescent ≥12 yr 30 IU/kg 3x wkly. Childn <12 yr Initially, 25 IU/kg every other day.
Sign Out
